Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Mar;25(3):359–366. doi: 10.1111/j.1365-2125.1988.tb03314.x

Influence of renal insufficiency on the pharmacokinetics of cicletanine and its effects on the urinary excretion of electrolytes and prostanoids.

N Ferry 1, J Geoffroy 1, N Pozet 1, G Cuisinaud 1, D Benzoni 1, P Y Zech 1, J Sassard 1
PMCID: PMC1386360  PMID: 3358898

Abstract

1. The kinetics of a single oral dose (300 mg) of cicletanine a new antihypertensive drug with diuretic properties, and its effects on the urinary excretion of electrolytes and of the major stable metabolites of prostacyclin and thromboxane A2 were studied in patients with normal renal function (n = 6), mild (n = 9) and severe (n = 10) renal insufficiency. 2. In normotensive subjects with normal renal function, cicletanine was rapidly and regularly absorbed, its apparent elimination half-life established around 7 h, and both its renal clearance (0.4 ml min-1) and its cumulative renal excretion (0.85% of the administered dose), were low. Mild renal insufficiency did not significantly alter these parameters, while severe renal impairment reduced the renal clearance and the cumulative urinary excretion of cicletanine and increased its apparent elimination half-life (31 h). However the area under the plasma curve was not changed due to reduced plasma concentrations in these patients. 3. Cicletanine induced a rapid and marked (four fold as a mean) increase in the urinary excretion of water, sodium and potassium which lasted for 6 to 10 h, in subjects with normal renal function. Renal insufficiency did not alter the slope of the calculated plasma concentration-effects curves but reduced the maximum effect observed for water, sodium and potassium. 4. A single oral dose of cicletanine did not change the urinary excretion of 6-keto-prostaglandin F1 alpha and thromboxane B2 in the three groups of patients studied, the basal values of which being found to be closely related to the creatinine clearance.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
359

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adithan C., Thangam J. A comparative study of saliva and serum paracetamol levels using a simple spectrophotometric method. Br J Clin Pharmacol. 1982 Jul;14(1):107–109. doi: 10.1111/j.1365-2125.1982.tb04944.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Benzoni D., Vincent M., Cuisinaud G., Sassard J. A new technique for the measurement of urinary 6-keto-prostaglandin F1 alpha: normal values in adults. Clin Chim Acta. 1982 Dec 23;126(3):283–289. doi: 10.1016/0009-8981(82)90302-3. [DOI] [PubMed] [Google Scholar]
  3. Ciabattoni G., Cinotti G. A., Pierucci A., Simonetti B. M., Manzi M., Pugliese F., Barsotti P., Pecci G., Taggi F., Patrono C. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med. 1984 Feb 2;310(5):279–283. doi: 10.1056/NEJM198402023100502. [DOI] [PubMed] [Google Scholar]
  4. Cuisinaud G., Terrier M., Ferry N., Proust S., Sassard J. High-performance liquid chromatographic determination of cicletanide, a new diuretic, in plasma, red blood cells, urine and saliva. J Chromatogr. 1985 May 31;341(1):97–104. doi: 10.1016/s0378-4347(00)84013-x. [DOI] [PubMed] [Google Scholar]
  5. Dorian B., Larrue J., Defeudis F. V., Salari H., Borgeat P., Braquet P. Activation of prostacyclin synthesis in cultured aortic smooth muscle cells by 'diuretic-antihypertensive' drugs. Biochem Pharmacol. 1984 Jul 15;33(14):2265–2269. doi: 10.1016/0006-2952(84)90665-8. [DOI] [PubMed] [Google Scholar]
  6. Düsing R., Scherhag R., Tippelmann R., Budde U., Glänzer K., Kramer H. J. Arachidonic acid metabolism in isolated rat aorta. Dependence of prostacyclin biosynthesis on extracellular potassium concentration. J Biol Chem. 1982 Feb 25;257(4):1993–1996. [PubMed] [Google Scholar]
  7. Garay R. P., Nazaret C., Diez J., Etienne A., Bourgain R., Braquet P., Esanu A. Stimulation of K+ fluxes by diuretic drugs in human red cells. Biochem Pharmacol. 1984 Jul 1;33(13):2013–2020. doi: 10.1016/0006-2952(84)90567-7. [DOI] [PubMed] [Google Scholar]
  8. Geoffroy J., Benzoni D., Sassard J. A new radioimmunoassay for urinary thromboxane B2 with prior purification by high performance liquid chromatography. Prostaglandins Leukot Med. 1985 Jun;18(3):393–399. doi: 10.1016/0262-1746(85)90072-1. [DOI] [PubMed] [Google Scholar]
  9. Guinot P., Frölich J. C. Study of the effects of cicletanine on prostanoids. Arzneimittelforschung. 1985;35(11):1714–1716. [PubMed] [Google Scholar]
  10. Koopmans P. P., Thien T., Thomas C. M., Van den Berg R. J., Gribnau F. W. The effects of sulindac and indomethacin on the anti-hypertensive and diuretic action of hydrochlorothiazide in patients with mild to moderate essential hypertension. Br J Clin Pharmacol. 1986 Apr;21(4):417–423. doi: 10.1111/j.1365-2125.1986.tb05216.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Levenson D. J., Simmons C. E., Jr, Brenner B. M. Arachidonic acid metabolism, prostaglandins and the kidney. Am J Med. 1982 Feb;72(2):354–374. doi: 10.1016/0002-9343(82)90826-9. [DOI] [PubMed] [Google Scholar]
  12. Mistry C. D., Lote C. J., Currie W. J., Vandenburg M., Mallick N. P. Effects of sulindac on renal function and prostaglandin synthesis in patients with moderate chronic renal insufficiency. Clin Sci (Lond) 1986 May;70(5):501–505. doi: 10.1042/cs0700501. [DOI] [PubMed] [Google Scholar]
  13. Webster J., Dollery C. T., Hensby C. N. Circulating prostacyclin concentrations may be increased by bendrofluazide in patients with essential hypertension. Clin Sci (Lond) 1980 Dec;59 (Suppl 6):125s–128s. doi: 10.1042/cs059125s. [DOI] [PubMed] [Google Scholar]
  14. Zipser R. D., Martin K. Urinary excretion of arterial blood prostaglandins and thromboxanes in man. Am J Physiol. 1982 Mar;242(3):E171–E177. doi: 10.1152/ajpendo.1982.242.3.E171. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES